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Introduction
Adenoviral (Ad) vectors are highly efficient transducers of cells that express adenoviral fibre protein receptor and ␣ v integrins required for virus internalisation. [1] [2] [3] [4] [5] Ad tropism for EC is normally lower than that for epithelial cells. 6 However, Ad vectors have been used successfully to express genes in EC, both in vitro 7, 8 and by cathetermediated local delivery in vivo. [9] [10] [11] [12] [13] Nevertheless, transduction efficiency can be considerably increased by complexing the virus with anti-␣ v integrin, using a bi-specific antibody (bsAb). 14 We proposed that transduction by Ad might be rendered specific to EC at sites of inflammation by complexing virus with an antibody to E-selectin. Eselectin is a single chain glycoprotein that acts as an adhesion ligand for the recruitment of leukocytes during inflammation. 15 It is found only on EC 16 and its expression requires transcriptional activation by inflammatory mediators such as interleukin-1 (IL-1) or tumour necrosis factor (TNF). 17 Importantly, surfaceexpressed E-selectin is rapidly re-internalised by endocytosis [18] [19] [20] [21] and this process has been shown to facilitate the uptake of anti-E-selectin-coated liposomes. 22 Ad complexed with anti-E-selectin might therefore not only selectively bind to cytokine-activated EC, but also be transported with E-selectin into endosomes. [23] [24] [25] In previous studies we have shown that it is possible to target E-selectin in vivo using a radiolabelled anti-E-selectin mAb, 1.2B6. 26 We thereby obtained quantitative data on E-selectin expression in models of cutaneous inflam- 21 December 1998 mation in the pig, [27] [28] [29] and scintigraphic images of inflamed tissues in patients with rheumatoid arthritis or inflammatory bowel disease. 30, 31 As a prelude to the possible use of mAb 1.2B6 for antibody-mediated gene delivery to activated endothelium in vivo, we have investigated whether the antibody could alter the tropism of Ad to allow specific transduction of cytokine-activated EC in vitro.
Results

E-selectin-mediated transduction of EC in culture
We conferred E-selectin tropism by complexing transgenic Ad5 expressing the FLAG peptide epitope in the penton base protein (AdZ.FLAG) with a bsAb formed by conjugating mAb 1.2B6 with anti-FLAG mAb M2 (1.2B6:FLAG). To demonstrate the functionality of this complex, we performed transduction assays on human umbilical vein EC (HUVEC) cultures followed by quantification of the lacZ gene product, ␤-galactosidase (␤-gal). As controls we used AdZ.FLAG alone, or complexed with a bsAb of irrelevant specificity (OKT3:FLAG). We observed a low level of transduction of resting HUVEC with AdZ.FLAG alone and this was significantly reduced by the presence of either 1.2B6:FLAG or OKT3:FLAG bsAb (P Ͻ 0.005 and P Ͻ 0.01, respectively) ( Figure 1a) . However, when HUVEC were stimulated with TNF and IL-1 (10 ng/ml and 1 ng/ml, respectively, for 6 h), there was a 20-fold increase in ␤-gal expression with the 1.2B6:FLAG.AdZ.FLAG complex (P Ͻ 0.0001) (Figure 1b ). This level was considerably greater than that seen with AdZ.FLAG alone, or complexed with OKT3:FLAG (P Ͻ 0.0001 for both comparisons). The increase in transduction mediated by 1.2B6:FLAG over that mediated by OKT3:FLAG was completely abrogated by pre-incubating the cells with 1.2B6 mAb (Figure 1c) . In contrast, preincubation of EC with recombinant soluble Ad5 fibre protein caused only a slight reduction in transduction by all three AdZ.FLAG complexes (P Ͻ 0.005) (Figure 1d ). However, the 1.2B6:FLAG-mediated increase in transduction was not affected.
We performed similar assays on porcine aortic EC (PAEC) cultures, using 1.2B6:FLAG and another control bsAb, made by conjugating mAb M2 to mAb 3E2, an antibody with specificity to murine but not porcine intercellular adhesion molecule 1 (3E2:FLAG). We observed a low level transduction of resting PAEC with all three complexes (Figure 2a) . When E-selectin was up-regulated on PAEC by TNF (10 ng/ml for 6 h), we again observed a significant (P Ͻ 0.0001) 25-fold increase in ␤-gal expression with the 1.2B6:FLAG complex. This was significantly greater than that seen with the 3E2:FLAG control bsAb (P Ͻ 0.0001) or in the absence of bsAb (P Ͻ 0.0001) ( Figure 2b) . As was the case with HUVEC, the increase in transduction by 1.2B6:FLAG.AdZ.FLAG was related to its binding E-selectin, as it was abrogated by pre-incubating the cells with 1.2B6 mAb (Figure 2c We carried out electron microscopy to observe the localisation of bsAb-complexed AdZ.FLAG. While typical Ad particles were frequently observed within endocytic vesicles of TNF-stimulated PAEC exposed to 1.2B6:FLAG.AdZ.FLAG (Figure 3) , no similar particles were demonstrated in EC exposed to 3E2:FLAG. AdZ.FLAG or in unstimulated cells exposed to 1.2B6:FLAG.AdZ.FLAG. The virus particles were around 50 nm diameter and were circular with a homogeneous central core surrounded by a halo of capsid proteins.
Transduction of porcine aortic explants
We then studied the transduction of EC within an intact vessel structure. In preliminary experiments we cultured segments of porcine aorta and immunostained for the presence of E-selectin. Aortic segments cultured in the presence of TNF (10 ng/ml) showed endothelial E-selectin expression within 4 h (Figure 4 ), whereas there was no detectable E-selectin expression before tissue culture or following culture in the absence of TNF. We conducted transduction assays on aortic segments using bsAb-complexed AdZ.FLAG, determining ␤-gal expression by Xgal staining. Aorta not exposed to Ad revealed no constitutive expression of ␤-gal, but that incubated with TNF and with 1.2B6:FLAG.AdZ.FLAG showed widespread, and in some areas confluent, ␤-gal expression by intimal EC (Figure 5 ). Morphometric analysis (Table 1) showed that 29% of intimal EC were transduced, compared with less than 0.1% in the absence of TNF and less than 0.01% in the presence of TNF with AdZ.FLAG alone or complexed with 3E2:FLAG. No transduction of medial smooth muscle cells was seen under any condition. 
methods). Unstimulated EC were poorly transduced (d, f). In contrast, TNF-stimulated EC showed ␤-gal expression in approximately 70% of cells (e), which was prevented by pre-incubation with mAb 1.2B6 (g). The Figure is representative of three experiments with similar results.
Discussion
Complexing Ad with anti-E-selectin mAb led to highly efficient and selective gene expression in cytokine-stimulated activated EC. We believe that the dramatic difference we have observed in transduction efficiency of activated versus resting EC is due to two properties of the bispecific antibody. Firstly, we established the specific involvement of E-selectin by showing inhibition of the increased transduction of activated EC in the presence of unconjugated anti-E-selectin mAb 1.2B6. Secondly, significant inhibition of transduction of resting EC was obtained by binding of the anti-FLAG antibody to Ad, suggesting interference with the normal mechanism of viral attachment and/or internalisation into cells. Indeed our unpublished data suggest that binding of the anti-FLAG antibody to the FLAG epitope expressed in the penton base inhibits the interaction of the neighbouring RGD sequence with ␣ v integrins. In view of a previous study demonstrating the difficulty of transducing aortic EC in situ with Ad, 32 33 and it may be possible to express this in transgenic Ad. An alternative approach could be to use an E-selectin-binding peptide, 34 although our recent attempt to express this in the Ad fibre was unsuccessful, possibly as a result of incorrect folding of the recombinant fibre protein. 6 However, both RGD, polylysine and FLAG motifs have been expressed in the fibre protein of intact virions, with functional re-targeting in vitro and in vivo. 6, 35 Taking our strategy forward in vivo presents several challenges. Firstly, high doses of Ad may be required to achieve effective blood levels. Secondly, the kinetics and mode of clearance of Ad from the circulation of large mammals have not been clearly defined and it is possible that Ad might be rapidly cleared by the liver and/or other organs, as occurs in rodents. 36 Thirdly, there is likely to be an immune response directed against antigen encoded by the virus or transgene and possibly against the bsAb.
37,38
Such an immune response might attenuate the therapeutic effect of transgene expression in inflammatory diseases. Finding ways of evading the natural clearance mechanisms and the antigenicity of Ad remains one of the major challenges in this field. [39] [40] [41] Notwithstanding, our data show that it is possible selectively to transduce cytokine-activated EC with Ad via E-selectin. Since E-selectin is expressed by endothelium in many inflammatory diseases, including rheumatoid arthritis, 42, 43 inflammatory bowel disease, 44 ,45 psoriasis 46 and atherosclerosis, 47, 48 this molecule may present a useful target for the directed delivery of genes aimed at modulating the inflammatory response in these disorders.
Materials and methods
Viruses and cell lines
The E1-and E3-deleted AdZ.FLAG vector was complexed with bispecific antibodies and grown as previously described. 14, 25 The vector expresses the FLAG epitope (DYKDDDDK) within the exposed RGD loop of the penton base. The vector also contains the lacZ gene under control of a cytomegalovirus (CMV) promoter. Purified, recombinant fibre knob protein (F5K), used as a competitor in viral transduction experiments, was produced and purified as previously described. 41 Briefly, the protein was produced in Tn5B1-4 insect cells (Invitrogen, San Diego, CA, USA) and was purified to homogeneity with 
Ni
++ nitrilotriacetic acid agarose columns as described by the manufacturer (Qiagen, Stanford, CA, USA). Primary HUVEC were obtained from the American Type Culture Collection (Rockville, MD, USA). The cells were maintained in MCDB medium (Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum (FCS). Porcine aortas were obtained from an abattoir and transported to the laboratory in Hank's balanced salt solution (HBSS) containing 50 U/ml penicillin, 50 g/ml streptomycin, 100 g/ml gentamicin, 1 mm sodium pyruvate and 0.1 g/ml amphotericin B (all from Gibco, Paisley, UK). They were either used directly in transduction experiments or to isolate EC using a modification of previously described methods. 49 Vessels were filled with collagenase A 0.25 mg/ml (Boehringer Mannheim, Lewes, UK) and incubated at 37°C for 15 min. Cells thereby obtained were cultured in gelatin-coated flasks in growth medium consisting of RPMI 1640 with 20% heatinactivated FCS (Gibco), 15 U/ml sodium heparin, 10 mm l-glutamine, 10 g/ml endothelial growth supplement (Sigma, Poole, UK) and antibiotics as above. Cultures were maintained for up to four passages.
Monoclonal and bispecific antibodies
Monoclonal antibody 1.2B6 is a murine IgG 1 against human and porcine E-selectin, 50, 51 and was purified from tissue culture supernatant by Protein A affinity chromatography. MOPC21 is a murine IgG 1 myeloma protein of undetermined specificity and was a kind gift of Dr Martyn Robinson (Celltech, Slough, UK). The anti-murine ICAM-1 mAb, 3E2, was obtained from PharMingen (San Diego, CA, USA). The anti-human CD3 mAb, OKT3, was purified from ascites fluid. The M2 anti-FLAG mAb was obtained from Kodak (Rochester, NY, USA). The bsAbs 1.2B6:FLAG, OKT3:FLAG and 3E2:FLAG were prepared by chemical cross-linking, as previously described. 21 Transduction of EC in culture and in situ Second to fifth passage HUVECs were seeded on to 24-well plates and were confluent the next day. Five hours before transduction with the AdZ.FLAG complexes, the medium in the wells was replaced with 300 l medium with or without 10 ng/ml TNF plus 1 ng/ml IL-1 (both from Boehringer Mannheim, IN, USA). One hour before transduction, the competitors F5K (5 g/ml final concentration), mAb 1.2B6 (50 g/ml), a combination of F5K and 1.2B6 mAb or no competitors, were pre-incubated with the cells. In parallel, AdZ.FLAG complexes were formed by pre-incubating 10 8 p.f.u. of AdZ.FLAG with 200 ng 1.2B6:FLAG, 200 ng OKT3:FLAG, or HBSS alone for 30 min in a volume of 0.1 ml. AdZ.FLAG complexes (10 7 p.f.u.) were then incubated with the cells for 1 h. The cells were washed twice and cultured for 18 h. Second to fourth passage PAEC were seeded on to gelatin-coated 24-well plates at 8 × 10 4 cells per well. One or two days later, when the cells were confluent, some wells were stimulated with 10 ng/ml recombinant human TNF (Bayer, CA, USA) for 6 h. Following this, mAbs 1.2B6 or MOPC21 at final concentrations of 20 g/ml were added to the culture medium for 1 h before the addition of the AdZ.FLAG complexes. Before addition to the PAEC, AdZ.FLAG (5.8 × 10 9 p.f.u./ml) was pre-incubated with 1.2B6:FLAG or 3E2:FLAG at 2 g/ml or HBSS alone for 30 min at 4°C. PAEC were incubated with the AdZ.FLAG complexes (3 × 10 7 p.f.u.) or with HBSS alone in a total volume of 0.5 ml for 1 h. The cell culture medium was then replaced and the cells cultured for 18 h. Porcine thoracic aorta segments (1-3 cm long) were placed in PAEC culture medium and incubated at 37°C in the presence or absence of TNF (10 ng/ml) for 1 h before the addition of the AdZ.FLAG complexes. Before addition to the aortic segments, AdZ.FLAG (5.8 × 10 9 p.f.u./ml) was pre-incubated with 1.2B6:FLAG or control bsAb at 2 g/ml or HBSS alone for 15 min at 4°C. Aortic segments were incubated with AdZ.FLAG complexes (3 × 10 8 p.f.u.) or with HBSS in 30 ml medium for 18 h.
Assays of ␤-gal expression
For histochemical evaluation of ␤-gal expression in PAEC, cells were washed in PBS and fixed for 10 min in a solution of 2% formamide and 0.2% glutaraldehyde in PBS, then washed twice in PBS. They were then incubated in X-gal solution, made up of 5 mm K 4 Fe(CN) 6 , 5 mm K 3 Fe(CN) 6 , 2 mm MgCl 2 , 200 g/ml X-gal (from 2% stock solution in N-N-dimethylformamide from NBL Gene Sciences, Cramlington, UK) in PBS for 5 h at 37°C. After washing, the cells were photographed. For quantification of ␤-gal expression by luminometry, cells were washed in ice-cold PBS and lysed with lysis buffer (Promega, Madison, WI, USA) containing 0.5 mm dithiothreitol. Lysates were stored at −70°C and later assayed with the Galactolight Plus kit (Tropix, Bedford, MA, USA). Luminometry readings were normalised for protein concentration in the lysates as determined by a modified Lowry or Bradford method. Group comparisons were made using Student's t test for independent variables. For histochemical evaluation of ␤-gal expression in aortic segments, the segments were washed and incubated with X-gal solution as described for PAEC and then cut into 5 mm blocks. Blocks were embedded in TissueTek OCT compound (Miles, Elkhart, IN, USA) and snap frozen. Five-micron sections were cut, mounted on polylysine-coated glass slides, counterstained with 0.1% nuclear fast red and cover-slipped with Aquamount (all from BDH, Poole, UK). For morphometric analysis at least three sections, more than 50 microns apart, were taken from three or more blocks from each aortic segment. The total number of blue cells was counted and expressed as a percentage of total EC number, ascertained by counting an adjacent section stained with haematoxylin and eosin. Mean values for each block were obtained and data for each aortic segment was presented as mean of these values ± s.e.m. Group comparisons were made using the Mann-Whitney U test.
Immunohistochemistry and electron microscopy Some aortic segments were snap-frozen 4 h after the addition of TNF. Five-micron sections were cut, mounted on to glass slides, air-dried and fixed for 10 min in acetone. After blocking with 20% normal rabbit serum (NRS; Dakopatts, Glostrup, Denmark), primary mAb (20 g/ml) were applied to sections for 1 h. Sections were then washed and secondary antibody and APAAP (Dakopatts) were applied in succession. Sections were developed with fast red (Sigma), counter-stained with Harris' haematoxylin and cover-slipped. For electron microscopy, TNF-activated or unstimulated PAEC growing confluently in 75 cm 2 tissue culture flasks were incubated with AdZ.FLAG complexes as above for 45 min, after which they were washed twice in Ca ++ -free HBSS and detached with trypsin-EDTA (ICN Flow, CA, USA). After neutralising the trypsin in culture medium the cells were pelleted and fixed in 2% paraformaldehyde. They were then washed in phosphate buffer, osmicated and dehydrated in a series of graded alcohols, being re-pelleted between each step. Pellets were embedded by immersing them in TAAB (Reading, UK) resin in capsules and the resin was polymerised overnight at 60°C. 1-m sections were stained with toluidine blue for observation at light microscope level, then ultrathin sections of approximately 100 nm were collected on nickel grids and stained with uranyl acetate and lead citrate. Sections were viewed with a Philips (Eindhoven, The Netherlands) CM-10 electron microscope.
